Anaergia Inc. (OTCMKTS:ANRGF – Get Rating)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $3.35 and traded as high as $4.41. Anaergia shares last traded at $4.36, with a volume of 15,950 shares changing hands.
Analyst Ratings Changes
A number of analysts recently issued reports on ANRGF shares. Stifel Nicolaus decreased their target price on shares of Anaergia from C$17.00 to C$10.00 in a research report on Tuesday, December 20th. TD Securities lowered their price objective on Anaergia from C$30.00 to C$10.00 in a research report on Friday, November 11th. National Bank Financial reduced their target price on Anaergia from C$10.00 to C$6.00 in a research report on Friday, December 9th. BMO Capital Markets lowered their price target on Anaergia from C$8.50 to C$7.00 in a report on Friday, December 9th. Finally, Scotiabank lowered shares of Anaergia from an “outperform” rating to a “sector perform” rating in a research report on Wednesday, November 30th.
Anaergia Stock Performance
The company has a 50 day simple moving average of $3.35 and a 200 day simple moving average of $5.37.
About Anaergia
Anaergia Inc, together with its subsidiaries, provides solutions for the generation of renewable energy and conversion of waste to resources. The company offers anaerobic digestion technologies for the production of clean energy, fertilizers, and recycled water from waste streams. It offers wastewater resource recovery, municipal solid waste, and agri-food solutions.
See Also
- Get a free copy of the StockNews.com research report on Anaergia (ANRGF)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Receive News & Ratings for Anaergia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anaergia and related companies with MarketBeat.com's FREE daily email newsletter.